Vidya Raman-Tangella - 01 Mar 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: CHIEF MEDICAL OFFICER
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol: TDOC
Transactions as of: 01 Mar 2024
Net transactions value: -$66,759
Form type: 4
Filing time: 05 Mar 2024, 16:08:54 UTC
Previous filing: 02 Feb 2024
Next filing: 20 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise		+3,169	+22%		17,906	01 Mar 2024	Direct	F1
transaction	TDOC	Common Stock	Options Exercise		+9,300	+52%		27,206	01 Mar 2024	Direct	F2
transaction	TDOC	Common Stock	Sale	$66,759	-4,599	-17%	$14.52	22,607	04 Mar 2024	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Performance Stock Units	Award	$0	+9,509		$0.000000	9,509	01 Mar 2024	Common Stock	9,509		Direct	F4, F5, F6
transaction	TDOC	Performance Stock Units	Options Exercise	$0	-3,169	-33%	$0.000000	6,340	01 Mar 2024	Common Stock	3,169		Direct	F1, F7
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-9,300	-33%	$0.000000	18,602	01 Mar 2024	Common Stock	9,300		Direct	F2, F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F2	Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F3	Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4	Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
F5	Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.
F6	The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F7	On March 1, 2024, the reporting person earned 9,509 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F8	On March 3, 2023, the reporting person was granted 27,902 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.